Diretriz
Diretriz
34
35
32.
Diagnostic and Statistical Manual of Mental Disorders. 4th. Text
revision ed. 1994, Washington, D. C.: Am Psych Assoc 551-557
33.
Hausken AM, Furu K, Skurtveit S, Engeland A, Bramness JG.
Starting insomnia treatment: the use of benzodiazepines versus
z-hypnotics. A prescription database study of predictors. Eur J
Clin Pharmacol 2009;65:295-301.
34.
GisevN,HartikainenS,ChenTF,KorhonenM,Bell JS.Mortality
associated with benzodiazepines and benzodiazepine-related
drugs among community-dwelling older people in Finland: a
population-based retrospective cohort study. Can J Psychiatry
2011;56:377-81.
35.
Kripke DF, Klauber MR, Wingard DL, Fell RL, Assmus JD,
Garfinkel L. Mortality hazard associated with prescription
hypnotics. Biol Psychiatry 1998;43:687-93.
36.
Lader M, Russell J. Guidelines for the prevention and treatment
of benzodiazepine dependence: summary of a report from
the Mental Health Foundation. Addiction 1993;88:1707–8.
37.
Roth T. A physiologic basis for the evolution of pharmacotherapy
for insomnia. J Clin Psychiatry 2007;68 Suppl 5:13-8.
38.
Sukys-Claudino L, Moraes WA, Tufik S, Poyares D.
The newer
sedative- hypnotics. Rev Bras Psiquiatr.2010;32:288-93.
39.
Richey SM, Krystal AD. Pharmacological Advances in the
treatment of insomnia. Curr Pharm Des 2011;17:1471-5.
40.
Morin CM, Bastien C, Guay B, Radouco-Thomas M, Leblanc J,
Vallières A. Randomized clinical trial of supervised tapering
and cognitive behavior therapy to facilitate benzodiazepine
discontinuation in older adults with chronic insomnia. Am J
Psychiatry 2004;161:332-42.
41.
Buscemi N, Vandermeer B, Friesen C, Bialy L, TubmanM, Ospina
M, et al. The efficacy and safety of drug treatments for chronic
insomnia in adults: a meta-analysis of RCTs. J Gen Intern Med
2007;22:1335-50.
42.
Pompéia S, Manzano GM, Tufik S, Bueno OF. What makes
lorazepam different from other benzodiazepines? J Physiol
2005;569(Pt2):709.
43.
Poyares D, Guilleminault C, Ohayon MM, Tufik S. Chronic
benzodiazepine usage and withdrawal in insomnia patients. J
Psychiatr Res 2004;38:327-34.
44.
Wilson KC, Saukkonen JJ. Acute respiratory failure from abused
substances. J Intensive Care Med 2004;19:183-93.
45.
Rančić N, Ignjatović Ristić D, Radovanović S, Kocić S, Radević
S. Sociodemographic and clinical characteristics of hospitalized
patients after suicide attempt: a twenty-year retrospective study.
Med Glas Ljek Komore Zenicko-doboj Kantona 2012;9:350-5.
46.
Kapur N, Turnbull P, Hawton K, Simkin S, Mackway-Jones K,
Gunnell D. The hospital management of fatal self-poisoning in
industrialized countries: an opportunity for suicide prevention?
Suicide Life Threat Behav 2006;36:302-12.
47.
Sein Anand J, Chodorowski Z, Ciechanowicz R, Klimaszyk D,
Lukasik-Głebocka M. Acute suicidal self-poisonings during
pregnancy. Przegl Lek. 2005;62:434-5.
48.
Spivey WH, Roberts JR, Derlet RW. A clinical trial of escalating
doses of flumazenil for reversal of suspected benzodiazepine
overdose in the emergency department. Ann Emerg Med
1993;22:1813-21.
49.
del Busto Prado F, Alvarez García A, Ibarra Peláez A, Menéndez
Fernándéz J, Barraca de Ramos R, Alonso Calo L. Significance of
flumazenil in acute benzodiazepine poisoning. Med Clin (Barc)
1990;94:616-8.
50.
Quaglio G, Faccini M, Vigneau CV, Casari R, Mathewson S, Licata
M, et al. Megadose bromazepam and zolpidem dependence: two
case reports of treatment with flumazenil and valproate. Subst
Abus 2012;33:195-8.
51.
Lugoboni F, Faccini M, Quaglio GL, Albiero A, Casari R, Pajusco
B. Intravenous flumazenil infusion to treat benzodiazepine
dependence should be performed in the inpatient clinical setting
for high risk of seizure. J Psychopharmacol 2011;25:848-9.
52.
van Broekhoven F, Kan CC, Zitman FG. Dependence potential
of antidepressants compared to benzodiazepines. Prog
Neuropsychopharmacol Biol Psychiatry 2002;26:939-43.
53.
Uzun S, Kozumplik O, Jakovljević M, Sedić B. Side effects of
treatment with benzodiazepines. Psychiatr Danub. 2010;22:90-
3.
54.
Schweizer E, Rickels K. Benzodiazepine dependence and
withdrawal: a review of the syndrome and its clinical
management. Acta Psychiatr Scand Suppl. 1998;393:95-101.
55.
Owen RT, Tyrer P. Benzodiazepine dependence. A review of
the evidence. Drugs 1983;25:385-98.




